456 related articles for article (PubMed ID: 32831998)
41. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
[TBL] [Abstract][Full Text] [Related]
42. Protein kinase CK2α catalytic subunit ameliorates diabetic renal inflammatory fibrosis via NF-κB signaling pathway.
Huang J; Chen Z; Li J; Chen Q; Li J; Gong W; Huang J; Liu P; Huang H
Biochem Pharmacol; 2017 May; 132():102-117. PubMed ID: 28237649
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Zhu Y; Zhu C; Yang H; Deng J; Fan D
Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
[TBL] [Abstract][Full Text] [Related]
44. SP600125 suppresses
Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
[TBL] [Abstract][Full Text] [Related]
45. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
46. Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice.
Chou YJ; Kan WC; Chang CM; Peng YJ; Wang HY; Yu WC; Cheng YH; Jhang YR; Liu HW; Chuu JJ
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649140
[TBL] [Abstract][Full Text] [Related]
47. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
[TBL] [Abstract][Full Text] [Related]
48. Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose.
Li YJ; Ma J; Loh YW; Chadban SJ; Wu H
Front Cell Dev Biol; 2023; 11():1182570. PubMed ID: 37215085
[No Abstract] [Full Text] [Related]
49. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
50. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
51. TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells.
Yang Z; Xiong F; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
Pharmacol Res; 2016 Sep; 111():226-236. PubMed ID: 27317945
[TBL] [Abstract][Full Text] [Related]
52. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway.
Xie Z; Zhong L; Wu Y; Wan X; Yang H; Xu X; Li P
Phytomedicine; 2018 Aug; 47():161-173. PubMed ID: 30166101
[TBL] [Abstract][Full Text] [Related]
53. Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK/NF-κB signaling pathway.
Han X; Zhang J; Zhou L; Wei J; Tu Y; Shi Q; Zhang Y; Ren J; Wang Y; Ying H; Liang G
Phytother Res; 2022 Jun; 36(6):2511-2523. PubMed ID: 35434887
[TBL] [Abstract][Full Text] [Related]
54. β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-κB.
Lee SU; In HJ; Kwon MS; Park BO; Jo M; Kim MO; Cho S; Lee S; Lee HJ; Kwak YS; Kim S
Biol Pharm Bull; 2013; 36(11):1754-9. PubMed ID: 23985900
[TBL] [Abstract][Full Text] [Related]
55. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
56. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
57. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
58. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
[TBL] [Abstract][Full Text] [Related]
59. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
Chem Biol Interact; 2014 Aug; 219():64-75. PubMed ID: 24877639
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.
Su J; Ren J; Chen H; Liu B
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
